These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35005999)

  • 1. Reasons for Intent to Discontinue and Remove Long-Acting Reversible Contraceptives: National Survey of Family Growth 2017-2019.
    Poleon S; Thompson EL
    J Womens Health (Larchmt); 2022 May; 31(5):733-740. PubMed ID: 35005999
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.
    Linton E; Mawson R; Hodges V; Mitchell CA
    BMJ Sex Reprod Health; 2023 Oct; 49(4):282-292. PubMed ID: 36810206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
    Sokol NA; Sawadogo N; Bullington BW; Tumlinson K; Langer A; Soura A; Zabre P; Sie A; Johnson JA; Senderowicz L
    Contraception; 2024 Jan; 129():110302. PubMed ID: 37802461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distribution and multilevel analysis of factors associated with long-acting reversible contraceptive use among sexually active women of reproductive age in Nigeria.
    Bolarinwa OA; Ajayi KV; Okeke SR; Hailegebreal S; Odimegwu C
    Arch Public Health; 2023 Jun; 81(1):99. PubMed ID: 37269016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with early long-acting reversible contraceptives discontinuation in Ethiopia: evidence from the 2016 Ethiopian demographic and health survey.
    Fekadu GA; Omigbodun AO; Roberts OA; Yalew AW
    Arch Public Health; 2020; 78():36. PubMed ID: 32626577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mobile video training for healthcare providers on long-acting reversible contraceptive (LARC) use among adolescents and young women.
    Xiong W; Li C; Liu X; Gui T; Peng P
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):686-692. PubMed ID: 34023522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
    Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
    Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
    Eeckhaut MCW; Rendall MS; Zvavitch P
    Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S; Rajbhandary R; Lohani S
    Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of reproductive health services among women using long- or short-acting contraceptive methods - a register-based cohort study from Finland.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Heikinheimo O; Laine MK
    BMC Public Health; 2022 Jun; 22(1):1185. PubMed ID: 35701805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.
    Vaaler ML; Kalanges LK; Fonseca VP; Castrucci BC
    Womens Health Issues; 2012 Mar; 22(2):e157-62. PubMed ID: 22265180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.
    Stancil SL; Miller MK; Duello A; Finocchario-Kessler S; Goggin K; Winograd RP; Hurley EA
    Harm Reduct J; 2021 Aug; 18(1):83. PubMed ID: 34348734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social Determinants of Health and Patient-Reported Difficult Discontinuation of Long-Acting Reversible Contraception.
    Hall B; Evans TA; Atrio JM; Danvers AA
    J Womens Health (Larchmt); 2024 Jul; ():. PubMed ID: 39034886
    [No Abstract]   [Full Text] [Related]  

  • 20. Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care.
    Jacinto A; Ronda AV; Lee C; Fikree FF; Ramirez-Ferrero E
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35040804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.